PHERIN PHARMACEUTICALS, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1991-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.pherin.com
Clinical Trials
3
Active:0
Completed:2
Trial Phases
2 Phases
Phase 2:1
Phase 3:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 3
2 (66.7%)Phase 2
1 (33.3%)Feasibility Study of PH94B Nasal Spray for Acute Treatment of Social Anxiety Disorder (SAD)
- First Posted Date
- 2015-12-07
- Last Posted Date
- 2015-12-07
- Lead Sponsor
- Pherin Pharmaceuticals, Inc.
- Target Recruit Count
- 23
- Registration Number
- NCT02622958
- Locations
- 🇺🇸
The Medical Research Network, LLC, New York City, New York, United States
Intranasal PH94B for Management of the Symptoms of Generalized Social Phobia
Phase 2
Completed
- Conditions
- Social PhobiaSocial Anxiety Disorder
- Interventions
- First Posted Date
- 2010-10-08
- Last Posted Date
- 2011-05-10
- Lead Sponsor
- Pherin Pharmaceuticals, Inc.
- Target Recruit Count
- 90
- Registration Number
- NCT01217788
- Locations
- 🇺🇸
Medical Research Network, New York City, New York, United States
Intranasal PH80 Spray for Acute Management of the Symptoms of Premenstrual Dysphoric Disorder
Phase 3
- Conditions
- Premenstrual Dysphoric Disorder
- Interventions
- Drug: Placebo intranasal spray
- First Posted Date
- 2010-10-08
- Last Posted Date
- 2015-12-03
- Lead Sponsor
- Pherin Pharmaceuticals, Inc.
- Target Recruit Count
- 1400
- Registration Number
- NCT01217775
- Locations
- 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
News
No news found